STOCK TITAN

Fortrea to Present at the Jefferies Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Fortrea (FTRE), a global contract research organization (CRO), announced that Chairman and Interim CEO Peter M. Neupert and CFO Jill McConnell will present at the Jefferies Global Healthcare Conference on June 5, 2025, at 8:45 am ET. Investors can access the live webcast through Fortrea's Investor Relations website, with a replay available after the event. The presentation represents an opportunity for the company to share updates and insights with the investment community.
Fortrea (FTRE), un'organizzazione globale di ricerca a contratto (CRO), ha annunciato che il Presidente e CEO ad interim Peter M. Neupert e la CFO Jill McConnell presenteranno alla Jefferies Global Healthcare Conference il 5 giugno 2025 alle 8:45 ET. Gli investitori potranno seguire la diretta streaming tramite il sito web delle Relazioni con gli Investitori di Fortrea, con la possibilità di rivedere la presentazione dopo l'evento. Questa presentazione rappresenta un'opportunità per l'azienda di condividere aggiornamenti e approfondimenti con la comunità degli investitori.
Fortrea (FTRE), una organización global de investigación por contrato (CRO), anunció que el presidente y CEO interino Peter M. Neupert y la CFO Jill McConnell presentarán en la Conferencia Global de Salud de Jefferies el 5 de junio de 2025 a las 8:45 am ET. Los inversores podrán acceder a la transmisión en vivo a través del sitio web de Relaciones con Inversores de Fortrea, con una repetición disponible después del evento. La presentación representa una oportunidad para que la empresa comparta actualizaciones e información con la comunidad inversora.
글로벌 임상시험수탁기관(CRO)인 Fortrea(FTRE)는 의장 겸 임시 CEO 피터 M. 뉴퍼트(Peter M. Neupert)와 CFO 질 맥코넬(Jill McConnell)이 2025년 6월 5일 오전 8시 45분(동부시간)에 Jefferies 글로벌 헬스케어 컨퍼런스에서 발표할 예정이라고 발표했습니다. 투자자들은 Fortrea의 투자자 관계 웹사이트를 통해 생중계에 접속할 수 있으며, 행사 후 다시보기 서비스도 제공됩니다. 이번 발표는 회사가 투자자 커뮤니티와 업데이트 및 인사이트를 공유할 수 있는 기회입니다.
Fortrea (FTRE), une organisation mondiale de recherche sous contrat (CRO), a annoncé que le président et PDG par intérim Peter M. Neupert ainsi que la directrice financière Jill McConnell présenteront lors de la Jefferies Global Healthcare Conference le 5 juin 2025 à 8h45 ET. Les investisseurs pourront accéder à la diffusion en direct via le site des relations investisseurs de Fortrea, avec une rediffusion disponible après l'événement. Cette présentation constitue une occasion pour l'entreprise de partager des mises à jour et des analyses avec la communauté des investisseurs.
Fortrea (FTRE), ein globales Auftragsforschungsinstitut (CRO), gab bekannt, dass Vorsitzender und Interims-CEO Peter M. Neupert sowie CFO Jill McConnell am 5. Juni 2025 um 8:45 Uhr ET auf der Jefferies Global Healthcare Conference präsentieren werden. Investoren können den Live-Webcast über die Investor-Relations-Website von Fortrea verfolgen, eine Aufzeichnung steht nach der Veranstaltung zur Verfügung. Die Präsentation bietet dem Unternehmen die Gelegenheit, der Investment-Community Updates und Einblicke zu vermitteln.
Positive
  • None.
Negative
  • None.

DURHAM, N.C., June 03, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that Chairman and Interim Chief Executive Officer, Peter M. Neupert and Chief Financial Officer, Jill McConnell will present at the Jefferies Global Healthcare Conference on Thursday, June 5, 2025 at 8:45 am ET.

The live webcast will be available to investors and other interested parties by accessing the Fortrea Investor Relations website. A webcast replay will be available after the event.

About Fortrea

Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in about 100 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com and follow us on LinkedIn and X (formerly Twitter).

Fortrea Contacts:

Hima Inguva (Investors) – 877-495-0816, hima.inguva@fortrea.com
Sue Zaranek (Media) – 919-943-5422, media@fortrea.com
Kate Dillon (Media) – 646-818-9115, kdillon@prosek.com


FAQ

When is Fortrea (FTRE) presenting at the Jefferies Healthcare Conference 2025?

Fortrea will present at the Jefferies Global Healthcare Conference on Thursday, June 5, 2025 at 8:45 am ET.

Who will represent Fortrea (FTRE) at the Jefferies Healthcare Conference?

Chairman and Interim CEO Peter M. Neupert and CFO Jill McConnell will represent Fortrea at the conference.

How can investors watch Fortrea's presentation at the Jefferies Conference?

Investors can watch the live webcast through Fortrea's Investor Relations website, with a replay available after the event.

What type of company is Fortrea (FTRE)?

Fortrea is a leading global contract research organization (CRO).
Fortrea Holdings

NASDAQ:FTRE

FTRE Rankings

FTRE Latest News

FTRE Stock Data

375.57M
90.15M
0.31%
105.63%
7.64%
Biotechnology
Services-medical Laboratories
Link
United States
DURHAM